Synthesis, molecular docking studies, and in vitro evaluation of 1,3,5-triazine derivatives as promising antimicrobial agents
作者:Vikrant Patil、Anurag Noonikara-Poyil、Shrinivas D. Joshi、Shivaputra A. Patil、Siddappa A. Patil、Abby M. Lewis、Alejandro Bugarin
DOI:10.1016/j.molstruc.2020.128687
日期:2020.11
was examined against five bacterial and two fungal strains. In vitro study revealed that the freshly synthesized 6-(thiazol-4-yl)-1,3,5-triazine-2,4-diamine (3o) showed good antibacterial growth inhibition against E. coli, K. pneumoniae, and A. baumannii bacterial strains, and even the fungi C. neoformans. Molecular docking studies were performed on the X-ray crystal structure of E. coli 24 kDa domain
摘要 六元环杂环1,3,5-三嗪及其衍生物由于被证明是优良的生物活性除草剂、抗癌剂等而备受关注。一系列1,3,5-三嗪衍生物(3a- o) 通过一步反应合成,并通过 1H NMR、13C NMR 和质谱分析进行表征。针对五种细菌和两种真菌菌株检查了标题化合物 (3a-o) 的抗菌筛选。体外研究表明,新合成的 6-(thiazol-4-yl)-1,3,5-triazine-2,4-diamine (3o) 对大肠杆菌、肺炎克雷伯菌和 A . baumannii 细菌菌株,甚至真菌 C. neoformans。对大肠杆菌 24 kDa 结构域与氯霉素(PDB 代码:1KZN;分辨率 2.30 A) 使用 Sybyl-X 软件的 Surflex-Dock 程序。获得的结果非常令人鼓舞。